Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Laurence W. Lytton Reports In 13G Filing A 9.99% Stake In Evoke Pharma

Author: Benzinga Newsdesk | March 13, 2024 02:02pm

https://www.sec.gov/Archives/edgar/data/1105806/000093583624000282/evok13g.htm

Posted In: EVOK

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist